<p>COVID-19
emerged as the biggest threat of this century for mankind and later it spread across the
globe through human to human transmission. Scientists rushed to understand the
structure and mechanism of the virus so that antiviral drugs or vaccines to
control this disease can be developed. A key to stop the progression of the
disease is to inhibit the replication mechanism of Sars-Cov-2. RNA-dependent-RNA polymerase
protein also called RdRp protein is the engine of Sars-Cov-2 that replicates
the virus using viral RNA when it gains entry into the human
cell. Numerous drugs proposed for the treatment of COVID-19 such as
Camostat Mesylate, Remdesivir, Famotidine, Hesperidin, etc. are under trial to
analyze the aftermath of their medicinal use. Nature is enriched with compounds
that have antiviral activities and can potentially play a pivotal role to
inhibit this virus. This study focuses on the phytochemicals that have the
potential to exhibit antiviral activities. A large number of
compounds were screened and a cohort of most suitable ones are suggested via
in-silico techniques which are used worldwide for drug discovery such as
docking, binding analysis, Universal Force Field Analysis, Broyden-Fletcher-Goldfarb-Shanno
(BFGS) Method, Molecular Dynamic Simulation, and Electrostatic
Potential Calculation. The proposed compounds are naturally occurring
substances with low toxicity, very few side effects, proven anti-pathogenic
effects, and most importantly are easily available.</p>